Showing 1 - 20 results of 55 for search 'Ramón García Sanz', query time: 0.07s
Refine Results
-
1
Long-term reversibility of renal dysfunction associated to light chain deposition disease with bortezomib and dexamethasone and high dose therapy and autologous stem cell transplan... by Tomás J. González-López, Lourdes Vázquez, Teresa Flores, Jesus Fernando San Miguel, Ramon García-Sanz
Published 2011-11-01
Article -
2
Genetics of Transformed Follicular Lymphoma by Miguel Alcoceba, María García-Álvarez, Jessica Okosun, Simone Ferrero, Marco Ladetto, Jude Fitzgibbon, Ramón García-Sanz
Published 2022-10-01
Article -
3
Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström’s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance by Patricia Martín-Jiménez, Ramón García-Sanz, Ana Balanzategui, Miguel Alcoceba, Enrique Ocio, Mª Luz Sanchez, Marcos González, Jesus San Miguel
Published 2007-05-01
Article -
4
Using quantification of the PML-RARα transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia by Carlos Santamaría, Maria Carmen Chillón, Carina Fernández, Patricia Martín-Jiménez, Ana Balanzategui, Ramón García Sanz, Jesús F. San Miguel, Marcos-Gonzalez González
Published 2007-03-01
Article -
5
Multiple myeloma with t(11;14): impact of novel agents on outcome by Borja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, Beatriz Rey-Bua, Irene Padilla, Ramón García-Sanz, Noemi Puig, Norma C. Gutiérrez, María-Victoria Mateos
Published 2023-03-01
Article -
6
Lymphoma Heterogeneity: Three Different Histological Pictures and One Unique Clone by Sara Alonso-Alvarez, Alba Redondo-Guijo, Óscar Blanco, Miguel Alcoceba, Ana Balanzategui, Juan C. Caballero, Julio Dávila, Marcos González, María D. Caballero, Alejandro Martín, Ramón García-Sanz
Published 2016-01-01
Article -
7
Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomat... by María E. Sarasquete, Norma C. Gutiérrez, Irena Misiewicz-Krzeminska, Bruno Paiva, María C. Chillón, Miguel Alcoceba, Ramón García-Sanz, Jesús M. Hernández, Marcos González, Jesús F. San-Miguel
Published 2011-03-01
Article -
8
DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma by Dalia Quwaider, Luis A. Corchete, Irena Misiewicz-Krzeminska, María E. Sarasquete, José J. Pérez, Patryk Krzeminski, Noemí Puig, María Victoria Mateos, Ramón García-Sanz, Ana B. Herrero, Norma C. Gutiérrez
Published 2017-04-01
Article -
9
Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma by Enrique M. Ocio, Julio Dávila, Juan-Carlos Caballero, Sara Alonso, Verónica González de la Calle, Ramón García-Sanz, Lucien Gazi, Socrates Opio, Mónica Jiménez, Jesús F. San-Miguel, María-Victoria Mateos
Published 2015-07-01
Article -
10
A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: biological and clinical utility by Irena Misiewicz-Krzeminska, Luis Antonio Corchete, Elizabeta A. Rojas, Joaquín Martínez-López, Ramón García-Sanz, Albert Oriol, Joan Bladé, Juan-José Lahuerta, Jesús San Miguel, María-Victoria Mateos, Norma C. Gutiérrez
Published 2018-05-01
Article -
11
Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines. by Teresa Paíno, María E Sarasquete, Bruno Paiva, Patryk Krzeminski, Laura San-Segundo, Luis A Corchete, Alba Redondo, Mercedes Garayoa, Ramón García-Sanz, Norma C Gutiérrez, Enrique M Ocio, Jesús F San-Miguel
Published 2014-01-01
Article -
12
Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication by Irena Misiewicz-Krzeminska, María E. Sarasquete, Dalia Quwaider, Patryk Krzeminski, Fany V. Ticona, Teresa Paíno, Manuel Delgado, Andreia Aires, Enrique M. Ocio, Ramón García-Sanz, Jesús F. San Miguel, Norma C. Gutiérrez
Published 2013-04-01
Article -
13
Genomic analysis of high-risk smoldering multiple myeloma by Lucía López-Corral, María Victoria Mateos, Luis A. Corchete, María Eugenia Sarasquete, Javier de la Rubia, Felipe de Arriba, Juan-José Lahuerta, Ramón García-Sanz, Jesús F. San Miguel, Norma C. Gutiérrez
Published 2012-09-01
Article -
14
Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance by Leandro S. Thiago, Martin Perez-Andres, Ana Balanzategui, Maria E. Sarasquete, Bruno Paiva, Maria Jara-Acevedo, Paloma Barcena, Maria Luz Sanchez, Julia Almeida, Marcos González, Jesus F. San Miguel, Ramón Garcia-Sanz, Alberto Orfao
Published 2014-01-01
Article -
15
The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia by Carlos Santamaría, María Carmen Chillón, Ramón García-Sanz, Ana Balanzategui, María Eugenia Sarasquete, Miguel Alcoceba, Fernando Ramos, Teresa Bernal, José Antonio Queizán, María Jesús Peñarrubia, Pilar Giraldo, Jesús F. San Miguel, Marcos Gonzalez
Published 2008-12-01
Article -
16
The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma by Bruno Paiva, Mauricio Chandia, Noemi Puig, Maria-Belen Vidriales, Jose J. Perez, Lucia Lopez-Corral, Enrique M. Ocio, Ramon Garcia-Sanz, Norma C. Gutierrez, Ana Jimenez-Ubieto, Juan-José Lahuerta, Maria-Victoria Mateos, Jesús F. San Miguel
Published 2015-02-01
Article -
17
P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN... by Alessandra Tedeschi, Constantine Tam, Roger Owen, Christian Buske, Véronique Leblond, Meletios A. Dimopoulos, Ramón García-Sanz, Jorge Castillo, Judith Trotman, Steven Treon, Keri Yang, Boxiong Tang, Heather Allewelt, Sheel Patel, Wai Chan, Aileen Cohen, Jingjing Yan Schneider, Gisoo Barnes
Published 2023-08-01
Article -
18
Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results by Josep‐Maria Ribera, Mireia Morgades, Jordi Ribera, Pau Montesinos, Isabel Cano‐Ferri, Pilar Martínez, Jordi Esteve, Daniel Esteban, María García‐Fortes, Natalia Alonso, José González‐Campos, Arancha Bermúdez, Anna Torrent, Eulàlia Genescà, Clara Maluquer, Joaquín Martínez‐López, Ramón García‐Sanz
Published 2024-04-01
Article -
19
Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-do... by María-Victoria Mateos, Sara Bringhen, Paul G. Richardson, Juan Jose Lahuerta, Alessandra Larocca, Albert Oriol, Mario Boccadoro, Ramón García-Sanz, Francesco Di Raimondo, Dixie-Lee Esseltine, Helgi van de Velde, Avinash Desai, Anil Londhe, Jesús F. San Miguel, Antonio Palumbo
Published 2014-06-01
Article -
20
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma by Esperanza M. Algarín, Dalia Quwaider, Francisco J. Campos-Laborie, Andrea Díaz-Tejedor, Pedro Mogollón, Elena Vuelta, Montserrat Martín-Sánchez, Laura San-Segundo, Lorena González-Méndez, Norma C. Gutiérrez, Ramón García-Sanz, Teresa Paíno, Javier De Las Rivas, Enrique M. Ocio, Mercedes Garayoa
Published 2021-03-01
Article